First, only transcriptomic expression of IDO1 and CD8A expression with clinical data was analyzed to predict prognosis in the colon cancer risk subgroups from public databases (TCGA and NCBI-GEO). This evidence concerns the gene CD8A and malignant colon neoplasm.